Viral latency
FoxO1 Suppresses Kaposi’s Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency
11
Activation of Vav by the Gammaherpesvirus M2 Protein Contributes to the Establishment of Viral Latency in B Lymphocytes
13
Inhibition of Superinfection and the Evolution of Viral Latency
9
p30 protein: a critical regulator of HTLV 1 viral latency and host immunity
15
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs
12
Induction of Protective Immunity against Murine Gammaherpesvirus 68 Infection in the Absence of Viral Latency
13
The Viral Latency-Associated Nuclear Antigen Augments the B-Cell Response to Antigen In Vivo
8
Myeloblastic Cell Lines Mimic Some but Not All Aspects of Human Cytomegalovirus Experimental Latency Defined in Primary CD34+ Cell Populations
11
Transcription of the Herpes Simplex Virus Latency-Associated Transcript Promotes the Formation of Facultative Heterochromatin on Lytic Promoters
9
Characterization of a Spontaneous 9.5-Kilobase-Deletion Mutant of Murine Gammaherpesvirus 68 Reveals Tissue-Specific Genetic Requirements for Latency
13
NF-κB p50 Plays Distinct Roles in the Establishment and Control of Murine Gammaherpesvirus 68 Latency
17
Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency
14
Murine Gammaherpesvirus 68 LANA Is Essential for Virus Reactivation from Splenocytes but Not Long-Term Carriage of Viral Genome
11
Neurodevelopmental assessment of HIV exposed uninfected and early treated HIV infected children: study protocol
5
Exhaustion and Inflation at Antipodes of T Cell Responses to Chronic Virus Infection
23
Altered human cytomegalovirus-encoded miRNAs in host circulation: novel disease biomarkers and potential aetiological agents
13
CD8 T Cells Control Cytomegalovirus Latency by Epitope-Specific Sensing of Transcriptional Reactivation
21
The Murine Gammaherpesvirus 68 M2 Gene Is Required for Efficient Reactivation from Latently Infected B Cells
14
Heterologous Viral Promoters Incorporated into the Human Cytomegalovirus Genome Are Silenced during Experimental Latency
9
Lungs are a major organ site of cytomegalovirus latency and recurrence.
7